However, St-Pierre notes, While some observational studies suggest associations with improved IBD-related outcomes, these findings should be interpreted cautiously given reliance on administrative data and surrogate end points. Overall, the available data are reassuring, St-Pierre says
There was no significant change over time for those with incomes $0-35K, and a small but significant decrease for those with incomes between $3550K (-0.011, p = 0.009) and $5080K (-0.012, p = 0.004) compared to the $035K group
Moreover, it slows down digestion so you feel fuller for longer after eating, enabling you to eat less overall
We advise against the use of these medications for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
Meet consumers where they are